Reuters logo
BRIEF-Cellectar Biosciences and Pierre Fabre extend collaboration
October 10, 2017 / 11:45 AM / 2 months ago

BRIEF-Cellectar Biosciences and Pierre Fabre extend collaboration

Oct 10 (Reuters) - Cellectar Biosciences Inc

* Cellectar Biosciences and Pierre Fabre extend collaboration for development of new phospholipid drug conjugates

* Cellectar Biosciences - ‍aim of extension is to further evaluate synergistic effects observed when Cellectar’s phospholipid ethers are combined with Pierre Fabre’s novel cytotoxic payloads​

* Cellectar Biosciences - ‍program teams will continue to evaluate the new PDC compounds Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below